Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

NCT00248547 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: aprepitant
DRUG: dexamethasone
DRUG: ondansetron
DRUG: placebo

Sponsor

OHSU Knight Cancer Institute